---
schema_version: "secwatch.filing_event.v1"
accession: "0000950103-24-017767"
form_type: "8-K"
ticker: "CRL"
cik: "0001100682"
company_name: "CHARLES RIVER LABORATORIES INTERNATIONAL, INC."
filed_at: "2024-12-13T23:59:59+00:00"
generated_at: "2026-05-29T03:18:32.725769+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Charles River amends credit agreement, cuts revolver to $2B, extends to 2029

## Summary
- Revolving commitments reduced from $3B to $2B; maturity extended to December 13, 2029.
- Subsidiary borrower Charles River Laboratories, Inc. added; obligations guaranteed by CRL and secured by assets.
- Interest rates based on SOFR/EURIBOR/Base rate plus margin tied to leverage ratio (Level I-III).
- Negative covenants limit additional indebtedness, liens, investments, mergers, and asset sales.
- Covenants include interest coverage and leverage ratio tests; customary events of default.

## SEC filing metadata
- accession: 0000950103-24-017767
- form_type: 8-K
- ticker: CRL
- cik: 0001100682
- company_name: CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- filed_at: 2024-12-13T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1100682/000095010324017767/0000950103-24-017767-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1100682/000095010324017767/dp222024_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950103-24-017767
- JSON: https://secwatch.observer/filing/0000950103-24-017767.json
- Plain text: https://secwatch.observer/filing/0000950103-24-017767.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.